Treatment with Cellgevity® improves glycemic index and prevents atherogenic dyslipidemia in Type 2 Diabetic rat model. Journal of Health Sciences, [S. l.], v. 3, n. 1, p. 24–31, 2025. Disponível em: https://lasujournals.ng/index.php/jhs/article/view/75. Acesso em: 12 may. 2026.